Access cutting-edge al amyloidosis treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access al amyloidosis specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related al amyloidosis treatment provided free
Open-label Phase 1b/2 study with primary objective of this study is to evaluate the safety, tolerability and efficacy of AZD0120 in participants with light chain (AL) amyloidosis.
Sponsor: Alexion Pharmaceuticals, Inc.
Check if you qualify for this al amyloidosis clinical trial in St Louis, MO
If you're searching for al amyloidosis treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced al amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.